Biogipuzkoa
Centro de investigación
Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (8)
2023
-
In-depth blood immune profiling of Good syndrome patients
Frontiers in Immunology, Vol. 14
2021
2018
-
In-depth proteomic characterization of classical and non-classical monocyte subsets
Proteomes, Vol. 6, Núm. 1
2015
-
Integration of proteomics and transcriptomics data sets for the analysis of a lymphoma B-cell line in the context of the chromosome-centric human proteome project
Journal of Proteome Research, Vol. 14, Núm. 9, pp. 3530-3540
2012
-
Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
Leukemia, Vol. 26, Núm. 8, pp. 1862-1869
2011
-
Comparison of immunofixation, serum free light chain, and immunophenotyping for response evaluation and prognostication in multiple myeloma
Journal of Clinical Oncology, Vol. 29, Núm. 12, pp. 1627-1633
2008
-
Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by paclitaxel for early breast cancer
Journal of the National Cancer Institute, Vol. 100, Núm. 11, pp. 805-814
2007
-
p73 cooperates with Ras in the activation of MAP kinase signaling cascade
Cell Death and Differentiation, Vol. 14, Núm. 2, pp. 254-265